Cite
APA Citation
Clark, C., Mosse, C., Chen, H., Byrne, M., Chinratanalab, W., Engelhardt, B., Goodman, S., Harrell, S., Kassim, A., Savani, B., Sengsayadeth, S., Jagasia, M., & Cornell, R. (2018). prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy. Bone marrow transplantation, 53, 1589–1592. http://access.bl.uk/ark:/81055/vdc_100099701082.0x000231